article thumbnail

USPTO Proposes Increase in Trademark-Related Fees - Effective November 2024

The TTABlog

Given the statutory and regulatory timeline for setting and adjusting fees, we anticipate any fee changes will be implemented on or around November 2024. The first steps in the fee adjustment process are to deliver our trademark fee proposal to the TPAC and engage the public.

article thumbnail

Mickey Mouse to Enter Public Domain in 2024

IPilogue

As the world entered January 2023, many excitedly anticipated that Disney’s copyright protection of Mickey Mouse in the United States (US) would expire at the end of 2023, allowing Mickey Mouse to enter the public domain as of January 1, 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bungie’s $7.7m Lawsuit Against ‘DMCA Fraudster’ Set For Jury Trial….in 2024

TorrentFreak

The date set by the court is April 15, 2024, and the trial itself is expected to last between three and five days. If the parties fail to reach a settlement, the case will go to a jury trial. A win is always a win, but beyond that, it’s hard to see any benefit for either side.

article thumbnail

Trial Scheduled for April 2024 in BMS Patent Case Against AstraZeneca Regarding Anti-PDL1 Antibodies

LexBlog IP

The District of Delaware has issued a scheduling order , setting a trial for April 2024, in Bristol Myers Squibb’s (BMS) patent case against AstraZeneca. The court has set a deadline for fact discovery to be completed by June 16, 2023, expert discovery to be completed by October 27, 2023, and a 5-day jury trial in April 2024.

Patent 52
article thumbnail

Trial Scheduled for April 2024 in BMS Patent Case Against AstraZeneca Regarding Anti-PDL1 Antibodies

JD Supra Law

The District of Delaware has issued a scheduling order, setting a trial for April 2024, in Bristol Myers Squibb’s (BMS) patent case against AstraZeneca. BMS filed its complaint against AstraZeneca on March 17, 2022, alleging infringement of eight patents related to anti-PD-L1 antibodies. By: Goodwin

Patent 52
article thumbnail

Canada Accedes to the Hague Apostille Convention

Cogency Global

What this is: As of January 11, 2024, Canada will issue apostilles for public Canadian documents, which will be accepted by all other countries currently party to the Hague Apostille Convention and will accept an apostille as confirmation of the authenticity of public documents from other member countries.

article thumbnail

This Week in Washington IP: Budget Hearings, Problems Posed by AI, and Government Use of Section 1498 for Private Patent Infringement

IP Watchdog

This week in Washington IP news, the Senate and House are back in session and holding a variety of hearings on departments’ 2024 budget requests, including for the Department of Commerce and the National Science Foundation (NSF).

IP 105